These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2408221)

  • 1. [Hyperlipidemia in diabetes mellitus. Pathogenesis, diagnosis and drug therapy--a review].
    Johansen K
    Ugeskr Laeger; 1990 Feb; 152(9):584-8. PubMed ID: 2408221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD; Banga JD; Erkelens DW
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):769-74. PubMed ID: 11346913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hyperlipidemia in diabetes mellitus.
    Dunn FL
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):395-414. PubMed ID: 1612072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
    Wolffenbuttel BH; Huijberts MS
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):761-5. PubMed ID: 11346911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hyperlipoproteinemia in patients with diabetes mellitus].
    Dammann HG; Dreyer M; Wernecke J; Lankers H; Müller P; Simon B
    Fortschr Med; 1990 May; 108(15):305-8. PubMed ID: 2204598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients.
    Seyoum B; Abdulkadir J; Berhanu P; Feleke Y; Mengistu Z; Worku Y; Ayana G
    Ethiop Med J; 2003 Jan; 41(1):1-8. PubMed ID: 12764995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy resistant hyperlipidemia].
    Saltevo J; Kunnamo I
    Duodecim; 1999; 115(13):1415,1419. PubMed ID: 11930881
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipids--diagnosis and therapy in type 2 diabetes].
    Wascher TC
    Acta Med Austriaca; 2004; 31(5):168-9. PubMed ID: 15747990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus.
    Pastromas S; Terzi AB; Tousoulis D; Koulouris S
    Int J Cardiol; 2008 May; 126(1):3-12. PubMed ID: 17689745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
    Iovine C; Lilli S; Gentile A; Patti L; Di Marino L; Cipriano P; Riccardi G; Rivellese AA
    Eur J Clin Invest; 2006 Aug; 36(8):560-5. PubMed ID: 16893378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.
    Durrington PN; Tuomilehto J; Hamann A; Kallend D; Smith K
    Diabetes Res Clin Pract; 2004 May; 64(2):137-51. PubMed ID: 15063607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperlipidemia: forestalling complications in older diabetics.
    Chait A
    Geriatrics; 1985 Apr; 40(4):71-3, 76-8. PubMed ID: 3884443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy for hyperlipidemia.
    Franklin FA; Margolis S
    Cardiovasc Clin; 1984; 14(3):265-84. PubMed ID: 6722855
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?].
    Broedl UC; Lehrke M; Parhofer KG
    MMW Fortschr Med; 2008 Jun; 150(25):41-3. PubMed ID: 18705054
    [No Abstract]   [Full Text] [Related]  

  • 18. [Poseidonol in the treatment of hyperlipidemia in patients with type 2 diabetes mellitus].
    Panchenko VM; Ershov AA; Isaev VA; ZImovchenko GS; Chernova GI
    Klin Med (Mosk); 2001; 79(6):47-9. PubMed ID: 11521381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic dyslipidemia: a case for aggressive intervention in the absence of clinical trial and cost effectiveness data.
    Lewis GF
    Can J Cardiol; 1995 May; 11 Suppl C():24C-28C. PubMed ID: 7750045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidemia in type 2 diabetes.
    Krauss RM; Siri PW
    Med Clin North Am; 2004 Jul; 88(4):897-909, x. PubMed ID: 15308384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.